"Comprehensive Outlook on Executive Summary Gastrointestinal Diseases Drug Development Market Size and Share CAGR Value The global gastrointestinal diseases drug development market size was valued at USD 39.60 billion in 2024 and is expected to reach USD 51.35 billion by 2032, at a CAGR of 3.30% during the forecast period Taking up Gastrointestinal...

The Newborn Screening Market has emerged as a vital segment of the healthcare diagnostics industry, driven by increasing awareness about early disease detection, government-led initiatives, and advancements in screening technologies. Newborn screening is a public health program aimed at the early identification of infants who may be affected by certain genetic, metabolic, hormonal, or...